Irregular heartbeat after valve surgery increases risk of stroke, death

Atrial Fibrillation increases the risk of stroke and other heart-related complications

5:00 AM

Author | Noah Fromson

heart organ yellow blue
Jacob Dwyer, Justine Ross, Michigan Medicine

In the days and weeks after heart surgery, up to half of patients may develop an irregular heartbeat, or atrial fibrillation. This can happen due to the stress of the procedure, which requires stopping the heart to operate.

This postoperative atrial fibrillation, commonly known as Afib, has traditionally been viewed as benign and limited. But a study led by researchers at the University of Michigan Health Frankel Cardiovascular Center finds that postoperative atrial fibrillation increases the risk of strokes and permanent Afib — and is linked to worse long term survival — after heart valve surgery.

The study is published in the Journal of Thoracic and Cardiovascular Surgery.

“Our results suggest that postoperative atrial fibrillation is more harmful that people once thought,” said Whitney Fu, M.D., first author and general surgery resident at University of Michigan Health.

“We are seeing a strong negative influence of post-op Afib on survival that is consistent with past research and suggests little improvement in addressing the issue.”

Hospitals without highest stroke care designation may miss them after heart procedure

The research team studied more than 900 cases of patients with no history of arrhythmias who had mitral valve surgery between 2011 to 2022. In total, 39% of patients had postoperative atrial fibrillation after surgery, and almost one-quarter of those patients developed new or recurrent Afib after 30 days.

Almost 5% of patients with postoperative atrial fibrillation experienced a neurologic event, such as stroke, for which permanent Afib is known to increase risk.

Atrial Fibrillation after heart valve surgery was also an independent risk factor for worse long term survival among patients who had mitral valve surgery.

TAVR: Less than one-third of patients enter cardiac rehab after heart procedure

“This high rate of atrial fibrillation after valve surgery and its potential severe downstream outcomes should encourage more research into the cause and prevention of postoperative Afib, as well as the development of guidelines to manage the condition,” said senior author Steven F. Bolling, M.D., cardiac surgeon at the Frankel Cardiovascular Center and professor of surgery at U-M Medical School.

Additional authors include China Green, Catherine Wagner, M.D., Gurnoordeep Pawar, Nicolas Ceniza, Rhea Gupta, Corina Ghita, Marco Bologna, Dani Ahmetovic, Tanvi Ravi, Jack Proebstle, Vivica Addrow, Matthew Romano, M.D., and Gorav Ailawadi, M.D., all of Michigan Medicine.

Romano is a consultant for Edwards Lifesciences, Medtronic, and Atricure. Ailawadi is a consultant for Abbott Laboratories, Edwards Lifesciences, Medtronic, Anteris Technologies, Atricure, and Gore Medical. Bolling is a consultant for Abbott Laboratories, Edwards Lifesciences, Medtronic, Atricure, and Gore Medical. Wagner received salary support through the Institute of Healthcare Policy and Innovation as a part of the National Clinician Scholars Program. Fu is supported by a National Institutes of Health T32 Multidisciplinary Training Program in Lung Disease (No. T32HL007749). All other authors reported no conflicts of interest.

Paper cited: “Postoperative atrial fibrillation in mitral valve surgery is not benign,” Journal of Thoracic and Cardiovascular Surgery. DOI: 10.1016/j.jtcvs.2023.08.057

More Articles About: All Research Topics Atrial fibrillation (Afib) Cardiovascular: Diseases & Conditions Arrhythmia or Abnormal Heart Rhythms Valve Disease Valve Repair and Replacement Stroke Treatment stroke Cardiovascular: Treatment & Surgery
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Featured News & Stories blood pressure cuff on mans arm with white coat doctor taking it
Health Lab
Blood pressure high for years? Beware of stroke risk
A study led by Michigan Medicine narrows in on the cumulative effects of years of high systolic blood pressure — the top number on the blood pressure reading and how hard the heart pumps blood to the arteries — finding that a higher average reading during adulthood is linked with a greater risk for the two most common types of stroke.
iv chemo bags
Health Lab
Drug-chemo combo increases cancer treatment efficacy
A study finds giving a fatty acid inhibitor alongside chemotherapy could improve the treatment efficacy for patients with brain metastases from triple negative breast cancer
white coats hanging and one swinging off hanger with purple haze over them and sunshine peeking through
Health Lab
Who feels ready for residency?
Helen Morgan, M.D., of Michigan Medicine, authored a study that surveyed obstetric and gynecology residents to determine who feels prepared for the transition from medical school to residency.
close up photo of yellow pills lined up on a bright blue matt
Health Lab
New drug candidate blocks resistance to cancer therapies
A team of researchers at the University of Michigan Health Rogel Cancer Center has designed a molecule that impairs signaling mediated by two key drivers of cancer therapy resistance.
two women, one older one younger, looking concerned listening to a provider across from them with back to camera
Health Lab
Many breast cancer survivors don't receive genetic testing, despite being eligible
As cancer treatment and survivorship care relies more on understanding the genetic make up of an individual’s tumor, a study from the University of Michigan Health Rogel Cancer Center finds that many breast cancer survivors who meet criteria for genetic counseling and testing are not receiving it.
rat in blue with yellow bright brain with blue abstract background
Health Lab
Diabetes and weight loss drugs could be enhanced, shows study in mice
A network of proteins found in the central nervous system could be harnessed to increase the effectiveness, and reduce the side effects, of diabetes and weight-loss drugs such as Ozempic and Mounjaro, according to research from the University of Michigan Life Sciences Institute.